Clinical Trial Update: Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update on long-term parenteral nutrition with SmofKabiven in cancer patients undergoing anticancer therapy; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Malnutrition

Drugs mentioned

• SmofKabiven

Snippet

Sponsor: Fresenius Kabi | Conditions: Cancer-related Malnutrition | Phase 4 | Status: TERMINATED